chr21-44658013-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000323084.9(TSPEAR):c.82+53420G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000411 in 1,461,528 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000323084.9 intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KRTAP12-3 | NM_198697.2 | c.34C>G | p.Pro12Ala | missense_variant | 1/1 | ENST00000397907.1 | NP_941970.2 | |
TSPEAR | NM_144991.3 | c.82+53420G>C | intron_variant | ENST00000323084.9 | NP_659428.2 | |||
TSPEAR | NM_001272037.2 | c.-123+32532G>C | intron_variant | NP_001258966.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KRTAP12-3 | ENST00000397907.1 | c.34C>G | p.Pro12Ala | missense_variant | 1/1 | NM_198697.2 | ENSP00000381005 | P1 | ||
TSPEAR | ENST00000323084.9 | c.82+53420G>C | intron_variant | 1 | NM_144991.3 | ENSP00000321987 | P1 | |||
TSPEAR | ENST00000642437.1 | c.*27+32532G>C | intron_variant, NMD_transcript_variant | ENSP00000496535 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1461528Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 727060
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 11, 2023 | The c.34C>G (p.P12A) alteration is located in exon 1 (coding exon 1) of the KRTAP12-3 gene. This alteration results from a C to G substitution at nucleotide position 34, causing the proline (P) at amino acid position 12 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.